Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Alzheimer's Disease

  Free Subscription

Articles published in J Neurol

Retrieve available abstracts of 44 articles:
HTML format

Single Articles

    March 2020
  1. IIZUKA T, Kameyama M
    Spatial metabolic profiles to discriminate dementia with Lewy bodies from Alzheimer disease.
    J Neurol. 2020 Mar 13. pii: 10.1007/s00415-020-09790.
    PubMed     Abstract available

    December 2019
  2. WEI G, Irish M, Hodges JR, Piguet O, et al
    Disease-specific profiles of apathy in Alzheimer's disease and behavioural-variant frontotemporal dementia differ across the disease course.
    J Neurol. 2019 Dec 23. pii: 10.1007/s00415-019-09679.
    PubMed     Abstract available

  3. GAETA AM, Benitez ID, Jorge C, Torres G, et al
    Prevalence of obstructive sleep apnea in Alzheimer's disease patients.
    J Neurol. 2019 Dec 12. pii: 10.1007/s00415-019-09668.
    PubMed     Abstract available

  4. KLOTH N, Lemke J, Wiendl H, Meuth SG, et al
    Serial position effects rapidly distinguish Alzheimer's from frontotemporal dementia.
    J Neurol. 2019 Dec 5. pii: 10.1007/s00415-019-09662.
    PubMed     Abstract available

    November 2019
  5. WANG X, Mao Z, Ling Z, Yu X, et al
    Repetitive transcranial magnetic stimulation for cognitive impairment in Alzheimer's disease: a meta-analysis of randomized controlled trials.
    J Neurol. 2019 Nov 23. pii: 10.1007/s00415-019-09644.
    PubMed     Abstract available

    October 2019
  6. DOORDUIJN AS, de van der Schueren MAE, van de Rest O, de Leeuw FA, et al
    Olfactory and gustatory functioning and food preferences of patients with Alzheimer's disease and mild cognitive impairment compared to controls: the NUDAD project.
    J Neurol. 2019 Oct 8. pii: 10.1007/s00415-019-09561.
    PubMed     Abstract available

    September 2019
  7. DE SIMONE MS, De Tollis M, Fadda L, Perri R, et al
    Lost or unavailable? Exploring mechanisms that affect retrograde memory in mild cognitive impairment and Alzheimer's disease patients.
    J Neurol. 2019 Sep 30. pii: 10.1007/s00415-019-09559.
    PubMed     Abstract available

  8. LAGARDE J, Olivieri P, Caille F, Gervais P, et al
    [(18)F]-AV-1451 tau PET imaging in Alzheimer's disease and suspected non-AD tauopathies using a late acquisition time window.
    J Neurol. 2019 Sep 18. pii: 10.1007/s00415-019-09530.
    PubMed     Abstract available

    July 2019
  9. ALTOMARE D, Ferrari C, Caroli A, Galluzzi S, et al
    Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset.
    J Neurol. 2019 Jul 2. pii: 10.1007/s00415-019-09441.
    PubMed     Abstract available

  10. BROWN J, Wiggins J, Lansdall CJ, Dawson K, et al
    Test Your Memory (TYM test): diagnostic evaluation of patients with non-Alzheimer dementias.
    J Neurol. 2019 Jul 2. pii: 10.1007/s00415-019-09447.
    PubMed     Abstract available

    June 2019
  11. BRUEGGEN K, Dyrba M, Cardenas-Blanco A, Schneider A, et al
    Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease based on multicenter diffusion tensor imaging.
    J Neurol. 2019 Jun 21. pii: 10.1007/s00415-019-09429.
    PubMed     Abstract available

  12. PERRI R, Monaco M, Fadda L, Caltagirone C, et al
    Influence of controlled encoding and retrieval facilitation on memory performance of patients with subcortical ischemic vascular dementia and Alzheimer's disease.
    J Neurol. 2019 Jun 18. pii: 10.1007/s00415-019-09411.
    PubMed     Abstract available

  13. BAYART JL, Hanseeuw B, Ivanoiu A, van Pesch V, et al
    Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Abeta42 and T-Tau assays for Alzheimer's disease diagnosis.
    J Neurol. 2019 Jun 10. pii: 10.1007/s00415-019-09418.
    PubMed     Abstract available

    May 2019
  14. TERADA T, Yokokura M, Obi T, Bunai T, et al
    In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer's disease.
    J Neurol. 2019 May 28. pii: 10.1007/s00415-019-09400.
    PubMed     Abstract available

  15. PERRY DC, Datta S, Miller ZA, Rankin KP, et al
    Factors that predict diagnostic stability in neurodegenerative dementia.
    J Neurol. 2019 May 17. pii: 10.1007/s00415-019-09362.
    PubMed     Abstract available

    April 2019
  16. SCHUMACHER J, Cromarty R, Gallagher P, Firbank MJ, et al
    Structural correlates of attention dysfunction in Lewy body dementia and Alzheimer's disease: an ex-Gaussian analysis.
    J Neurol. 2019 Apr 21. pii: 10.1007/s00415-019-09323.
    PubMed     Abstract available

  17. OKUDA S, Tetsuka J, Takahashi K, Toda Y, et al
    Association between sleep disturbance in Alzheimer's disease patients and burden on and health status of their caregivers.
    J Neurol. 2019 Apr 9. pii: 10.1007/s00415-019-09286.
    PubMed     Abstract available

  18. MANCA C, Rivasseau Jonveaux T, Roch V, Marie PY, et al
    Amyloid PETs are commonly negative in suspected Alzheimer's disease with an increase in CSF phosphorylated-tau protein concentration but an Abeta42 concentration in the very high range: a prospective study.
    J Neurol. 2019 Apr 8. pii: 10.1007/s00415-019-09315.
    PubMed     Abstract available

  19. SLACHEVSKY A, Forno G, Barraza P, Mioshi E, et al
    Mapping the neuroanatomy of functional decline in Alzheimer's disease from basic to advanced activities of daily living.
    J Neurol. 2019 Apr 4. pii: 10.1007/s00415-019-09260.
    PubMed     Abstract available

    March 2019
  20. MANUEL AL, Foxe D, Bradshaw N, Cordato NJ, et al
    Sustained attention failures on a 3-min reaction time task is a sensitive marker of dementia.
    J Neurol. 2019 Mar 5. pii: 10.1007/s00415-019-09261.
    PubMed     Abstract available

    February 2019
  21. MAZZEO S, Padiglioni S, Bagnoli S, Bracco L, et al
    The dual role of cognitive reserve in subjective cognitive decline and mild cognitive impairment: a 7-year follow-up study.
    J Neurol. 2019;266:487-497.
    PubMed     Abstract available

    January 2019
  22. JIN B, Liu H
    Comparative efficacy and safety of therapy for the behavioral and psychological symptoms of dementia: a systemic review and Bayesian network meta-analysis.
    J Neurol. 2019 Jan 21. pii: 10.1007/s00415-019-09200.
    PubMed     Abstract available

    November 2018
  23. DE SIMONE MS, Perri R, Fadda L, Caltagirone C, et al
    Predicting progression to Alzheimer's disease in subjects with amnestic mild cognitive impairment using performance on recall and recognition tests.
    J Neurol. 2018 Nov 1. pii: 10.1007/s00415-018-9108.
    PubMed     Abstract available

  24. AHMED RM, Goldberg ZL, Kaizik C, Kiernan MC, et al
    Neural correlates of changes in sexual function in frontotemporal dementia: implications for reward and physiological functioning.
    J Neurol. 2018;265:2562-2572.
    PubMed     Abstract available

    August 2018
  25. ONG SS, Proia AD, Whitson HE, Farsiu S, et al
    Ocular amyloid imaging at the crossroad of Alzheimer's disease and age-related macular degeneration: implications for diagnosis and therapy.
    J Neurol. 2018 Aug 28. pii: 10.1007/s00415-018-9028.
    PubMed     Abstract available

  26. PICKRELL WO, Robertson NP
    New treatments in Alzheimer's disease.
    J Neurol. 2018 Aug 21. pii: 10.1007/s00415-018-9018.

  27. CHANDRA A, Dervenoulas G, Politis M
    Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment.
    J Neurol. 2018 Aug 17. pii: 10.1007/s00415-018-9016.
    PubMed     Abstract available

  28. BOUGEA A, Stefanis L, Paraskevas GP, Emmanouilidou E, et al
    Neuropsychiatric symptoms and alpha-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.
    J Neurol. 2018 Aug 6. pii: 10.1007/s00415-018-8992.
    PubMed     Abstract available

  29. WEI H, Zhu X, Li Y
    Application value of serum biomarkers for choosing memantine therapy for moderate AD.
    J Neurol. 2018;265:1844-1849.
    PubMed     Abstract available

    April 2018
  30. ROALF DR, Rupert P, Mechanic-Hamilton D, Brennan L, et al
    Quantitative assessment of finger tapping characteristics in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease.
    J Neurol. 2018 Apr 4. pii: 10.1007/s00415-018-8841.
    PubMed     Abstract available

    February 2018
  31. AVGERINOS KI, Kalaitzidis G, Malli A, Kalaitzoglou D, et al
    Intranasal insulin in Alzheimer's dementia or mild cognitive impairment: a systematic review.
    J Neurol. 2018 Feb 1. pii: 10.1007/s00415-018-8768.
    PubMed     Abstract available

    December 2017
  32. EDWARDS M, Robertson NP
    Seizures in Alzheimer's disease: is there more beneath the surface?
    J Neurol. 2017 Dec 4. pii: 10.1007/s00415-017-8694.

    September 2017
  33. DE SIMONE MS, Perri R, Fadda L, De Tollis M, et al
    Different deficit patterns on word lists and short stories predict conversion to Alzheimer's disease in patients with amnestic mild cognitive impairment.
    J Neurol. 2017 Sep 25. doi: 10.1007/s00415-017-8623.
    PubMed     Abstract available

  34. LIGUORI C, Chiaravalloti A, Nuccetelli M, Izzi F, et al
    Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease.
    J Neurol. 2017 Sep 12. doi: 10.1007/s00415-017-8613.
    PubMed     Abstract available

  35. CECCHINI MA, Yassuda MS, Bahia VS, de Souza LC, et al
    Recalling feature bindings differentiates Alzheimer's disease from frontotemporal dementia.
    J Neurol. 2017 Sep 11. doi: 10.1007/s00415-017-8614.
    PubMed     Abstract available

    August 2017
  36. KARAVASILIS E, Parthimos TP, Papatriantafyllou JD, Papageorgiou SG, et al
    A specific pattern of gray matter atrophy in Alzheimer's disease with depression.
    J Neurol. 2017 Aug 30. doi: 10.1007/s00415-017-8603.
    PubMed     Abstract available

  37. CAI Z, Wan CQ, Liu Z
    Astrocyte and Alzheimer's disease.
    J Neurol. 2017 Aug 18. doi: 10.1007/s00415-017-8593.
    PubMed     Abstract available

  38. HRASTELJ J, Robertson N
    Genetics of disease severity in multiple sclerosis, Alzheimer's disease, and Huntington's disease: rejuvenating genome-wide association studies.
    J Neurol. 2017 Aug 7. doi: 10.1007/s00415-017-8584.

    January 2017
  39. MALIK GA, Robertson NP
    Treatments in Alzheimer's disease.
    J Neurol. 2017 Jan 24. doi: 10.1007/s00415-017-8395.

    December 2016
  40. TYNKKYNEN J, Hernesniemi JA, Laatikainen T, Havulinna AS, et al
    High-sensitivity cardiac troponin I and NT-proBNP as predictors of incident dementia and Alzheimer's disease: the FINRISK Study.
    J Neurol. 2016 Dec 30. doi: 10.1007/s00415-016-8378.
    PubMed     Abstract available

  41. KIMURA A, Takemura M, Saito K, Yoshikura N, et al
    Comparison of cerebrospinal fluid profiles in Alzheimer's disease with multiple cerebral microbleeds and cerebral amyloid angiopathy-related inflammation.
    J Neurol. 2016 Dec 20. doi: 10.1007/s00415-016-8362.
    PubMed     Abstract available

    October 2016
  42. CASTRO P, Zaman S, Holland A
    Alzheimer's disease in people with Down's syndrome: the prospects for and the challenges of developing preventative treatments.
    J Neurol. 2016.
    PubMed     Abstract available

  43. BORRELLO L, Cupidi C, Lagana V, Anfossi M, et al
    Angela R.: a familial Alzheimer's disease case in the days of Auguste D.
    J Neurol. 2016.
    PubMed     Abstract available

    May 2016
  44. MASCALCHI M, Bessi V, Ginestroni A, Toschi N, et al
    Low MT ratio in hippocampus of amnestic MCI patients who will progress to AD.
    J Neurol. 2016;263:1024-6.

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.